5-Year Outcomes After Left Atrial Appendage Closure

医学 心房颤动 华法林 随机对照试验 心脏病学 临床终点 内科学 外科 冲程(发动机) 机械工程 工程类
作者
Vivek Y. Reddy,Shephal K. Doshi,Saibal Kar,Douglas Gibson,Matthew J. Price,Kurt Huber,Rodney Horton,Maurice Buchbinder,Petr Neužil,Nicole Gordon,David R. Holmes
出处
期刊:Journal of the American College of Cardiology [Elsevier BV]
卷期号:70 (24): 2964-2975 被引量:803
标识
DOI:10.1016/j.jacc.2017.10.021
摘要

The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that left atrial appendage closure (LAAC) with the Watchman device (Boston Scientific, St. Paul, Minnesota) was equivalent to warfarin for preventing stroke in atrial fibrillation, but had a high rate of complications. In a second randomized trial, PREVAIL (Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy), the complication rate was low. The warfarin cohort experienced an unexpectedly low ischemic stroke rate, rendering the efficacy endpoints inconclusive. However, these outcomes were based on relatively few patients followed for a relatively short time. The final results of the PREVAIL trial, both alone and as part of a patient-level meta-analysis with the PROTECT AF trial, are reported with patients in both trials followed for 5 years. PREVAIL and PROTECT AF are prospective randomized clinical trials with patients randomized 2:1 to LAAC or warfarin; together, they enrolled 1,114 patients for 4,343 patient-years. Analyses are by intention-to-treat, and rates are events per 100 patient-years. For the PREVAIL trial, the first composite coprimary endpoint of stroke, systemic embolism (SE), or cardiovascular/unexplained death did not achieve noninferiority (posterior probability for noninferiority = 88.4%), whereas the second coprimary endpoint of post-procedure ischemic stroke/SE did achieve noninferiority (posterior probability for noninferiority = 97.5%); the warfarin arm maintained an unusually low ischemic stroke rate (0.73%). In the meta-analysis, the composite endpoint was similar between groups (hazard ratio [HR]: 0.820; p = 0.27), as were all-stroke/SE (HR: 0.961; p = 0.87). The ischemic stroke/SE rate was numerically higher with LAAC, but this difference did not reach statistical significance (HR: 1.71; p = 0.080). However, differences in hemorrhagic stroke, disabling/fatal stroke, cardiovascular/unexplained death, all-cause death, and post-procedure bleeding favored LAAC (HR: 0.20; p = 0.0022; HR: 0.45; p = 0.03; HR: 0.59; p = 0.027; HR: 0.73; p = 0.035; HR: 0.48; p = 0.0003, respectively). These 5-year outcomes of the PREVAIL trial, combined with the 5-year outcomes of the PROTECT AF trial, demonstrate that LAAC with Watchman provides stroke prevention in nonvalvular atrial fibrillation comparable to warfarin, with additional reductions in major bleeding, particularly hemorrhagic stroke, and mortality. (WATCHMAN Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation; NCT00129545; and Evaluation of the WATCHMAN LAA Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin Therapy; NCT01182441)
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
不过尔尔完成签到 ,获得积分10
1秒前
刘宏完成签到,获得积分10
2秒前
可以完成签到,获得积分10
2秒前
3秒前
坚强枫完成签到,获得积分10
4秒前
默默的巧荷完成签到,获得积分10
5秒前
一叶知秋完成签到,获得积分10
6秒前
小杰瑞完成签到,获得积分20
6秒前
希望天下0贩的0应助可以采纳,获得10
6秒前
白色梨花发布了新的文献求助10
6秒前
7秒前
包容柜子发布了新的文献求助10
7秒前
fiell完成签到,获得积分10
8秒前
眼睛大的擎苍给眼睛大的擎苍的求助进行了留言
8秒前
呆萌滑板完成签到 ,获得积分10
9秒前
9秒前
瑶瑶完成签到,获得积分10
10秒前
小猪找库里完成签到,获得积分10
11秒前
zhuzhen007完成签到 ,获得积分10
12秒前
淡定的秀发完成签到,获得积分10
12秒前
xuan完成签到,获得积分10
14秒前
龙华之士发布了新的文献求助10
14秒前
mkb发布了新的文献求助10
14秒前
sl发布了新的文献求助10
15秒前
隐形尔蝶发布了新的文献求助10
16秒前
17秒前
17秒前
仙林AK47完成签到,获得积分10
17秒前
无花果应助包容柜子采纳,获得10
17秒前
chen完成签到,获得积分10
18秒前
iNk应助河丫采纳,获得20
20秒前
小马甲应助清浅采纳,获得10
21秒前
清爽笑翠完成签到 ,获得积分10
22秒前
量子星尘发布了新的文献求助10
22秒前
25秒前
早岁完成签到,获得积分10
25秒前
mkb关闭了mkb文献求助
25秒前
隐形尔蝶完成签到,获得积分10
26秒前
自由老头发布了新的文献求助100
29秒前
monair完成签到 ,获得积分10
29秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038446
求助须知:如何正确求助?哪些是违规求助? 3576149
关于积分的说明 11374627
捐赠科研通 3305875
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892680
科研通“疑难数据库(出版商)”最低求助积分说明 815048